CA
Chathurappan Anbazhagan
About Chathurappan Anbazhagan
Data last updated:
Chathurappan Anbazhagan is a Whole-Time Director at Surien Pharmaceuticals Private Limited (since 2018). The company operates in Pharma. Surien Pharmaceuticals Private Limited reported revenue of ₹16.68 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Surien Pharmaceuticals Private Limited U24232TN2004PTC053031 | Whole-Time Director | 11 Oct 2018 | 2004 | ₹16.68 Cr (FY 2025) | Active |
Board colleagues of Chathurappan Anbazhagan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gowri Krishnamoorthy | 02107937 | Surien Pharmaceuticals Private Limited | Director |
| Ramasamy Krishnamoorthy | 01651885 | Surien Pharmaceuticals Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chathurappan Anbazhagan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chathurappan Anbazhagan
Chathurappan Anbazhagan currently holds 1 directorship: Surien Pharmaceuticals Private Limited (Whole-Time Director, since 11 Oct 2018, revenue ₹16.68 Cr (FY 2025)).
Chathurappan Anbazhagan was first appointed on 11 Oct 2018 as Whole-Time Director at Surien Pharmaceuticals Private Limited.
The current boards of Chathurappan Anbazhagan's companies include Gowri Krishnamoorthy (Surien Pharmaceuticals Private Limited), Ramasamy Krishnamoorthy (Surien Pharmaceuticals Private Limited).